Shraddha Subramanian

The University of Texas MD Anderson Cancer Center

Also affiliated with Brown Foundation, The University of Texas Health Science Center at Houston

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “An antibody-drug conjugate targeting GPR56 demonstrates efficacy in preclinical models of colorectal cancer”.

An antibody-drug conjugate targeting GPR56 demonstrates efficacy in preclinical models of colorectal cancer

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.08.11.503187

N/A

0DataRank · unranked

10 citations

Liezl E. Francisco, Treena Chatterjee, Zhengdong Liang, Shraddha Subramanian, Qingyun J. Liu +3 more

Loss of LGR5 through plasticity or gene ablation is associated with therapy resistance and enhanced MET-STAT3 signaling in colorectal cancer cells

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.01.482539

N/A

0DataRank · unranked

2 citations

Joan Jacob, Ashlyn Parkhurst, Shraddha Subramanian, Liezl E. Francisco, Zhengdong Liang +2 more

An antibody–drug conjugate targeting GPR56 demonstrates efficacy in preclinical models of colorectal cancer

British Journal of Cancer(2023)10.1038/s41416-023-02192-3

N/A

0DataRank · unranked

24 citations

Liezl E. Francisco, Treena Chatterjee, Zhengdong Liang, Shraddha Subramanian, Qingyun J. Liu +3 more

Loss of LGR5 through Therapy-induced Downregulation or Gene Ablation Is Associated with Resistance and Enhanced MET-STAT3 Signaling in Colorectal Cancer Cells

Molecular Cancer Therapeutics(2023)10.1158/1535-7163.mct-22-0415

N/A

0DataRank · unranked

17 citations

Joan Jacob, Ashlyn Parkhurst, Shraddha Subramanian, Liezl E. Francisco, Zhengdong Liang +2 more

The Evolving Paradigm of Antibody–Drug Conjugates Targeting the ErbB/HER Family of Receptor Tyrosine Kinases

Pharmaceutics(2024)10.3390/pharmaceutics16070890

N/A

0DataRank · unranked

14 citations

Cara Guernsey-Biddle, Shraddha Subramanian, Joan Jacob, Kendra S. Carmon, Peyton C. High

Cetuximab increases LGR5 expression and augments LGR5-targeting antibody-drug conjugate efficacy in patient-derived colorectal cancer models

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.102363

N/A

0DataRank · unranked

2 citations

Zhengdong Liang, Cara Guernsey-Biddle, Shraddha Subramanian, Yueh-Ming Shyu, Adela M. Aldana +3 more

Cetuximab increases LGR5 expression and augments LGR5-targeting antibody-drug conjugate efficacy in patient-derived colorectal cancer models

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.06.18.660406

N/A

0DataRank · unranked

2 citations

Zhengdong Liang, Cara Guernsey-Biddle, Shraddha Subramanian, Yueh-Ming Shyu, Adela M. Aldana +3 more